Literature DB >> 21963106

HbA(1c) targets for type 2 diabetes: how many, …how far!

Dario Giugliano1, Antonio Ceriello, Katherine Esposito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21963106     DOI： 10.1016/j.diabres.2011.09.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


× No keyword cloud information.
  2 in total

1.  Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes?

Authors:  Katherine Esposito; Antonio Ceriello; Dario Giugliano
Journal:  Endocrine       Date:  2013-03-12       Impact factor: 3.633

Review 2.  Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.

Authors:  Annalisa Capuano; Liberata Sportiello; Maria Ida Maiorino; Francesco Rossi; Dario Giugliano; Katherine Esposito
Journal:  Drug Des Devel Ther       Date:  2013-09-17       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.